ADA: Depressive Symptoms In Diabetics Worsen Glycemic Control
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




ADA: Depressive Symptoms In Diabetics Worsen Glycemic Control

By Jill Stein
Special to DG News

PHILADELPHIA, PA -- June 25, 2001 -- New findings indicate that depression impairs glycemic control over time, according to study findings reported here yesterday during the 61st Scientific Sessions of the American Diabetes Association (ADA).

Dr. William H. Polonsky, with the University of California, San Diego, said that depression also may attenuate the positive impact of diabetes treatment interventions.

At the Tripler Army Medical Center in San Diego, 158 patients with poorly controlled type 2 diabetes participated in a one-year treatment intervention study.

Patients were randomly assigned to an experimental intervention or a control intervention. The experimental intervention involved an intensive 3 ½ day educational and medical management protocol followed by nurse care management over 12 months. The control intervention involved quarterly mailings of relevant educational materials.

A self-report questionnaire was completed and hemoglobin A1c (HbA1c) levels were obtained at baseline and at 12 months. The Center for Epidemiological Studies Depression Scale (CES-D), a widely used scale for depression screening, was also included.

Dr. Polonsky presented results in the first 61 patients in whom a 12-month HbA1c level was obtained.

Baseline CES-D was positively associated with baseline HbA1c and also with HbA1C at follow-up after adjustment for baseline HbA1c. Further adjustment for the treatment condition did not affect this latter finding, suggesting that the influence of depressive symptoms on future glycemic control was independent of the experimental intervention. In fact, treatment condition did not lead to a significant change in CES-D at follow-up.

Notably, the change in CES-D over the one-year period was not associated with the change in HbA1c.

Dr. Polonsky pointed out that, as in prior cross-sectional studies, this investigation found that depression was common in diabetes and linked to poor glycemic control. However, he was quick to point out that the patients in this series were not representative of the general population in that all of them had elevated HbA1c levels and the ethnic mix was not typical.

He also noted that self-care behavior changes did not mediate the link between depression and future glycemic control, suggesting that depression-related physiologic changes may be to blame and that more careful assessment of self-care behaviors is needed.

Finally, he said that early and aggressive treatment of depression may be extremely important for improving glycemic control, especially when combined with standard diabetes treatment interventions.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities